Medtronic (NYSE:MDT) owes $15.4 million to bone cement maker Pabban Development for breaking the terms their 2008 acquisition deal, a federal jury in California ruled last week.
Spine
K2M prices IPO under range at $132M
K2M Group cut the price on its initial public offering to $15 per share, with trading in the stock slated to begin today on the NASDAQ exchange under the KTWO symbol.
NuVasive claims win in patent spat with Cadwell Labs
NuVasive Inc. (NSDQ:NUVA) said today that Cadwell Laboratories agreed to settle a patent spat over neuromonitoring technology by exiting the lateral spine market and potentially paying 5% royalties to NuVasive for future products.
Medtronic inks $22M deal to settle 950 Infuse lawsuits
Report: Mainstay Medical’s IPO raises $25M
Mainstay Medical‘s (MSTY.PA) European initial public offering reeled in about $25 million (€18 million) and made the spinal implant maker the 1st medtech company to float an IPO in Paris and the 1st company to attempt a dual flotation in Paris and Dublin, the Irish Times reports.
Legal loss pushes NuVasive to Q1 red
NuVasive Inc. (NSDQ:NUVA) swung to a 1st-quarter loss after a jury ruled against it in a trademark infringement battle with NeuroVision, prompting the medical device company to lower its 2014 earnings outlook and investors to pare more than 2% from its share price.
SI-Bone has big plans for newly raised $33M
San Jose, Calif.-based SI-Bone has big plans for its newly raised $33 million, saying it’ll use the new funds to add additional resources and chase regulatory approvals overseas for its iFuse bone fixation system.
Financing came from new investors Orbimed and Novo A/S, as well as from existing funders Skyline Ventures and Montreux Equity Partners, SI-Bone reported.
Aurora Spine touts FDA wins for spinal fixation devices
California spinal devices maker Aurora Spine touted a pair of FDA wins, landing clearance for additional sizes of its ZIP ULTRA spinal fusion system and additional clearance for the company’s ZIP MIS.
Spine: Baxano Surgical closes $10M private placement
K2M’s IPO could reap as much as $183M
K2M Group Holdings, the largest privately held spinal implant maker, said today that its forthcoming initial public offering could be worth up to $183 million.
K2M announced its plans for a U.S. IPO early this year, saying in March that the launch could be worth $100 million.
Medline nabs Amendia’s cervical spinal surgery tech in closed-doors deal
Illinois-based Medline Industries acquired key spine surgery technologies from Georgia-based Amendia, the companies announced this month.
Medline nabbed Amendia’s anterior cervical fusion distraction pin business, part of a market that Medline expects to grow more than 8% annually. The technologies are used in surgeries for removing problem disks in the neck area of the spine.